Literature DB >> 1918709

Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study.

J J Patel1, D Shama, A S Mitha, D Blyth, F Hassen, B T Le Roux, S Chetty.   

Abstract

Closed surgical mitral valvotomy is the procedure of choice in most patients with symptomatic pliable mitral stenosis in developing countries. The procedure is efficacious and safe. Mitral valvotomy performed with a balloon has shown similar good results, with infrequent complications in selected subjects. Because there is a paucity of studies comparing the two techniques, this study was undertaken to compare the results of percutaneous balloon mitral valvuloplasty with those of closed commissurotomy as determined by catheterization studies. Forty-five patients with tight pliable mitral stenosis were randomly assigned to one of two groups: 23 patients had balloon valvuloplasty by the single catheter technique (group I) and 22 underwent closed surgical valvotomy (group II). The two groups were similar with regard to clinical and hemodynamic findings before intervention. Mitral valve area increased from 0.8 +/- 0.3 to 2.1 +/- 0.7 cm2 in group I (p less than 0.001) and from 0.7 +/- 0.2 to 1.3 +/- 0.3 cm2 in group II (p less than 0.001). Pulmonary artery pressure and pulmonary vascular resistance decreased in both groups, but these changes did not reach statistical significance in group II. Treadmill exercise time increased from 3.8 +/- 2.3 to 7.3 +/- 2.6 min in group I (p less than 0.001) and from 4 +/- 2.6 to 5.6 +/- 2.6 min in group II (p less than 0.001). There were no deaths. One patient in each group developed moderate (3+) mitral regurgitation. A small interatrial shunt (less than 1.5:1) was detected in three patients in group I immediately after the procedure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1918709     DOI: 10.1016/0735-1097(91)90555-n

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Balloon dilatation of heart valves.

Authors:  Z G Turi; B S Fromm
Journal:  BMJ       Date:  1992-11-28

2.  Significance of commissural calcification on outcome of mitral balloon valvotomy.

Authors:  N Sutaria; D B Northridge; T R Shaw
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 3.  Percutaneous mitral balloon valvuloplasty.

Authors:  C E Mayes; J E Cigarroa; R A Lange; L D Hillis
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

4.  Percutaneous transvenous mitral commissurotomy in elderly mitral stenosis patients. A retrospective study at shahid gangalal national heart centre, bansbari, kathmandu, Nepal.

Authors:  Chandra Mani Adhikari; Rabi Malla; Rajib Rajbhandari; Yadav Kumar Bhatta; Arun Maskey; Suman Thapaliya; Prakash Gurung; Kc Man Bahadur
Journal:  Maedica (Buchar)       Date:  2013-09

5.  Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over.

Authors:  N Sutaria; A T Elder; T R Shaw
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

6.  Laceration of anterior mitral leaflet postpercutaneous balloon mitral valvuloplasty for rheumatic mitral stenosis.

Authors:  Mehmood Jadoon; M J Roberts; L Dixon; Mark Jones
Journal:  BMJ Case Rep       Date:  2012-12-14

7.  Anaesthetic management of closed mitral valvotomy for severe mitral stenosis with traumatic kyphoscoliosis.

Authors:  Am Jagadeesh; N Manjunath; Venugopal Ram Rao; Sunitha A Sathyakumari
Journal:  Indian J Anaesth       Date:  2010-01

8.  Mitral balloon valvuloplasty.

Authors:  Mohamed Eid Fawzy
Journal:  J Saudi Heart Assoc       Date:  2010-05-11

Review 9.  [Diagnosis and differential therapy of mitral stenosis].

Authors:  D Fassbender; H K Schmidt; H Seggewiss; H Mannebach; N Bogunovic
Journal:  Herz       Date:  1998-11       Impact factor: 1.443

10.  Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy.

Authors:  T R D Shaw; N Sutaria; B Prendergast
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.